It offers an in-depth perspective on the work of the Agency’s departments, outlines priority topics addressed at the international level, and presents innovations in medicines regulation as well as within the Agency itself. The report also highlights areas of our work that often receive less public attention but remain vital to ensuring the safety and effectiveness of healthcare in Estonia.
“We are committed to shaping the future of healthcare both in Estonia and internationally. Whether by strengthening national oversight, improving access to innovative services, contributing to broader healthcare policy discussions, or engaging in the development of new EU pharmaceutical regulations, our goal is to support Estonia’s healthcare system to the fullest extent possible — with knowledge, data, and expertise,” said Katrin Kiisk, Director General of the State Agency of Medicines.
In addition to the annual summaries, the report highlights the advancement of Estonia’s pharmaceutical sector, progress in strategic and IT development, as well as the outcomes of national and international cooperation initiatives.
The full Annual Report is available HERE.
